Health topic
Cancer
Prostate, breast, lung and colorectal cancer — screening guidelines, survivorship and disparities in outcomes.
The number
<5%
Of clinical trial participants are Black
Why it matters
Treatments are tested on populations that do not reflect the patients receiving them.
- Ask if a trial is right for you
- Get screened on schedule
- Request a second opinion
- Use patient navigators — they are free
Articles
View all newsroom
Latest · Cancer
Younger Black Women Face Widening Survival Gap in Uterine Cancer
A long-term study reveals that the survival gap between Black and white uterine cancer patients is widest among women diagnosed under age 50.
August 19, 2026 · Source: Kaiser Permanente Division of Research
Cancer
Insured Black Patients Face Lower Endometrial Cancer Survival Rates Despite Equal Treatment, Study Finds
A new study reveals that equal insurance coverage and standard treatments are not enough to eliminate racial disparities in advanced endometrial cancer survival.
August 19, 2026 · Source: Bioengineer.org
Cancer
Socioeconomic Vulnerability Linked to Lower Ovarian Cancer Survival Among Black Women
A recent study highlights how neighborhood-level social vulnerability compounds racial disparities in ovarian cancer survival rates for Black women.
August 19, 2026 · Source: CancerNetwork
Cancer
National Cancer Institute Grant Targets Basic Science of Cancer Disparities
Federal grant funding aims to support basic scientific research exploring the biological mechanisms driving unequal cancer outcomes in minority communities.
August 19, 2026 · Source: Oncodaily
Cancer
Closing the Gap: What Data and Frontline Experiences Reveal About Cancer in Black California
Data and frontline reports highlight the deep structural barriers driving higher cancer mortality among Black Californians, underscoring the urgent need for a diverse medical workforce.
August 7, 2026 · Source: BlackPressUSA
Cancer
Black Diamond Therapeutics Reports Encouraging Silevertinib Data for Targeted Lung Cancer Treatment
Promising clinical trial results for the targeted lung cancer therapy silevertinib open new regulatory avenues while underscoring the vital need for equitable access to precision oncology.
August 7, 2026 · Source: Yahoo Finance
Cancer
Promising Phase 2 Trial Results Highlight Advances in Targeted Lung Cancer Therapy
Phase 2 clinical trial results show a targeted lung cancer therapy delayed disease progression by more than 15 months, highlighting the potential of precision medicine.
August 7, 2026 · Source: Yahoo Finance